INFUSOR, PRESSURE, BL

The contract specifies the procurement of 12 disposable pressure infusor blood collecting-dispensing bags, each with a 1000ml capacity, featuring a built-in gauge, bulb, dual-pressure safety valve, one-handed pressurization and deflation functionality, and a rigid hanger designed to slip securely over IV poles without puncturing the fluid bag. The device is non-sterile, with dimensions of 7.25 inches in width, 6.00 inches in thickness, and 11.75 inches in length, and is packaged in a box containing 12 units. The product must have a minimum 36-month shelf life, with no more than five months having elapsed from the manufacturer’s date to the government’s delivery date. Packaging and marking must strictly conform to MIL-STD-2073-1E for packaging, MIL-STD-129 for shipment labeling and barcoding, and the Medical Marking Standard No. 1 for medical device identification. The item is identified by NSN 6515-01-706-5795 and is subject to DLA’s technical and quality requirements accessible via their master list. Delivery is FOB destination to Fort Lewis, Washington, with a 20-day window from the order date, and payment must be made electronically through the Wide Area WorkFlow system. The solicitation, issued under SPE2DS-26-T-039G, is a simplified acquisition utilizing an LPTA methodology with price as the primary evaluation factor, contingent upon mandatory compliance with NIST SP 800-171 cybersecurity standards and the submission of a current assessment score. Offerors must provide their UEI and CAGE codes, accurately represent small business status and socioeconomic certifications, and demonstrate compliance with DFARS cybersecurity clauses including safeguarding controlled defense information and prohibiting the use of covered telecommunications equipment. All hazardous materials must be labeled per the Hazard Communication Standard and MIL-STD-129, and contractors are required to submit MSDS for non-covered hazardous substances prior to award. The contract includes clauses on equal opportunity, trafficking in persons, employment eligibility verification, sustainable products, and whistleblower rights under deviations and standard FAR and DFARS provisions.